References
- Amsel L. P., Hinsvark O. N., Rotenberg K., Sheumaker J. L. Recent advances in sustained-release technology using ion-exchange polymers. Pharmaceutical Technology 1984; 8: 28–48
- Aronsen K. F., Hellekant C., Holmberg J., Rothman U., Teder H. Controlled blocking of hepatic artery flow with enzymatically degradable microspheres combined with oncolytic drugs. European Surgery Research 1979; 11: 99–106
- Baker R. W., Tuttle M. E., Helwing R. Novel erodible polymers for the delivery of macromolecules. Pharmaceutical Technology 1984; 8: 26–30
- Bostrom S., Brown D. W. Spherodized albumin (human) microspheres and lung imaging. Journal of Nuclear Medicine 1971; 12: 474
- Davis M. A., Taube R. A. PULMONARY PERFUSION IMAGING. ACUTE TOXICITY AND SAFETY FACTORS AS A FUNCTION OF PARTICLE SIZE. JOURNAL OF NUCLEAR MEDICINE 1978b; 19: 1206–1213
- Davis S. S. Recent advances in biopharmaceutics. Drug delivery systems, 2nd European Congress on Biopharmacy and Pharmacokinetics, Proceedings. Salamanca 1984; Vol. I
- Gürkan H., Yalabik-Kaç H. S., Hincal A. A., Ercan M. T. Streptomycin sulphate microspheres formulation and in vivo distribution. Journal of Microencapsul-ation 1986; 3: 101–108
- Hashida M., Takahashi Y., Muranishi S., Sezaki H. An application of water-in-oil and gelatin-microsphere-in-oil emulsions to specific delivery of anticancer agent into stomach lymphatics. Journal of Pharmacokinetics and Biopharmacy 1977; 5: 241–255
- Hashida M., Muranishi S., Sezaki H., Tanigawa N., Satomura K., Hikasa Y. Increased lymphatic delivery of bleomycin by microspheres in oil emulsion and its effect on lymph-node metastasis. International Journal of Pharmacy 1979; 2: 245–256
- Hashida M., Yoshioka T., Muranishi S., Sezaki H. DOSAGE FORM CHARACTERISTICS OF MICROSPHERE-IN-OIL EMULSIONS. I. STABILITY AND DRUG RELEASE. CHEMICAL PHARMACEUTICAL BULLETIN 1980b; 28: 1009–1015
- Kojima T., Hashida M., Muranishi S., Sezaki H. Antitumor activity of timed-release derivative of mitocycin C, Agarose bead conjugate. Chemical Pharmaceutical Bulletin 1978; 26: 1818–1824
- Lee T. K., Sokoloski T. D., Royer G. P. Serum albumin beads. An injectable, biodegradable system for the sustained release of drugs. Science 1981; 213: 233–235
- Raban P., Gregora V., Sindelar J., Alvarez-Cervera J. Two alternative techniques of labelling iron-free albumin microspheres with 99mTc and 113mIn. Journal of Nuclear Medicine 1973; 14: 344–345
- Rhodes B. A., Zolle I., Buchanan J. W., Wagner H. N. Radioactive albumin microspheres for studies of the pulmonary circulation. Nuclear Medicine 1969; 92: 1453–1460
- Russell G. F. J. Starch microspheres as drug delivery systems. Pharmacy International 1983; 4: 260–262
- Scheffel U., Rhodes B. A., Natarajan T. K., Jr., Wagner H. N., Jr. Albumin microspheres for study of the reticuloendothelial system. Journal of Nuclear Medicine 1972b; 13: 498–503
- Eenyei A. E., Reich S. D., Gonczy C., Widder K. J. In vivo kinetics of magnetically targetted low-dose doxorubicin. Journal of Pharmaceutical Science 1981; 70: 389–391
- Tomlinson E., Burger J. J., Schoolderwoerd E. M. A., McVie J. G. Human serum albumin microspheres for intra-arterial drug targetting of cytostatic compounds. Microspheres and Drug Therapy, S. S. Davis, L. Illum, J. G. McVie, E. Tomlinson. Elsevier, Amsterdam 1984; 75–89
- Verdon T. A., Jr., Anger H. O., Yano Y., Dyke D. V. 99mTc-spherodized albumin (human) microspheres for lung imaging. Journal of Nuclear Medicine 1971; 12: 469–470
- Wahbi A. M., Abdine H., Sadek A. R. H. The spectrophotometric determination of streptomycins. Pharmazie 1977; 32: 690–692
- Widder K., Flouret G., Senyei A. Magnetic microspheres. Synthesis of a novel parenteral drug carrier. Journal of Pharmaceutical Science 1979; 68: 79–82
- Yoshioka T., Hashida M., Muranishi S., Sezaki H. Specific delivery of mitomycin C to the liver, spleen and lung. Nano- and microspherical carriers of gelatin. International Journal of Pharmacy 1981; 81: 131–134